Boston Scientific stock closed down, better than sector, upcoming earnings report, mixed analyst opinions.

From NASDAQ.: 2025-04-17 18:15:00

Boston Scientific (BSX) closed at $95.12, down -0.14% from the previous session, underperforming S&P 500. Shares dropped 5.44% in the last month, better than Medical sector. Earnings report on April 23, 2025, forecasts an EPS of $0.67 and revenue of $4.56 billion. Zacks Rank of #3 (Hold). Forward P/E ratio of 33.44, PEG ratio of 2.52, industry rank 184 out of 250+.

Investors urged to track analyst projections for Boston Scientific. Zacks Rank system indicates stock performance based on revisions. Company currently holds a Zacks Rank of #3 (Hold). Industry rank in Medical sector is 184 out of 250+. Special offer from Zacks Investment Research to access all picks for $1 for 30 days. Opportunity to explore portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators and more.

Zacks Investment Research provides insights into Boston Scientific’s valuation metrics. Forward P/E ratio of 33.44, PEG ratio of 2.52 reflecting premium compared to industry averages. Medical – Products industry has Zacks Industry Rank of 184, in bottom 26% of all industries. Top 50% rated industries outperform bottom half by 2 to 1 ratio. Investors can monitor stock-influencing metrics on Zacks.com.



Read more at NASDAQ.: Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors